Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Ptc Therapeutics, Inc. (PTCT) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Ptc Therapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1070081.
Total stock buying since 2014: $2,873,267.
Total stock sales since 2014: $245,518,876.
Total stock option exercises since 2014: $83,020,063.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2026 | 0 | $0 | 61,121 | $4,702,465 | 18,376 | $622,430 |
| 2025 | 0 | $0 | 663,353 | $43,621,574 | 578,926 | $18,856,404 |
| 2024 | 0 | $0 | 267,949 | $12,763,806 | 239,318 | $11,047,100 |
| 2023 | 7,700 | $198,737 | 214,175 | $10,799,632 | 166,395 | $4,559,349 |
| 2022 | 0 | $0 | 68,378 | $2,990,348 | 38,293 | $717,179 |
| 2021 | 0 | $0 | 180,252 | $11,094,247 | 163,599 | $3,284,523 |
| 2020 | 10,000 | $324,850 | 1,859,640 | $108,450,293 | 1,825,289 | $32,745,192 |
| 2019 | 66,225 | $1,999,995 | 374,190 | $16,993,244 | 338,350 | $5,179,366 |
| 2018 | 0 | $0 | 28,583 | $1,205,849 | 20,000 | $217,000 |
| 2017 | 25,000 | $337,225 | 78 | $921 | 21,216 | $230,193 |
| 2016 | 2,000 | $12,460 | 0 | $0 | 89,216 | $967,992 |
| 2015 | 0 | $0 | 536,059 | $32,874,651 | 363,962 | $4,588,811 |
| 2014 | 0 | $0 | 417 | $21,846 | 417 | $4,524 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2026-01 | 0 | $0 | 61,121 | $4,702,465 | 18,376 | $622,430 |
| 2025-12 | 0 | $0 | 76,250 | $5,815,212 | 88,733 | $3,995,871 |
| 2025-11 | 0 | $0 | 153,645 | $12,580,440 | 153,645 | $4,209,454 |
| 2025-10 | 0 | $0 | 136,524 | $9,058,521 | 132,858 | $4,539,587 |
| 2025-09 | 0 | $0 | 114,804 | $6,796,223 | 109,936 | $3,202,576 |
| 2025-08 | 0 | $0 | 15,219 | $775,890 | 2,813 | $72,265 |
| 2025-07 | 0 | $0 | 12,580 | $622,205 | 0 | $0 |
| 2025-04 | 0 | $0 | 3,701 | $178,769 | 0 | $0 |
| 2025-03 | 0 | $0 | 108,391 | $5,781,257 | 90,941 | $2,836,651 |
| 2025-02 | 0 | $0 | 22,479 | $1,126,429 | 0 | $0 |
| 2025-01 | 0 | $0 | 19,760 | $886,628 | 0 | $0 |
| 2024-12 | 0 | $0 | 209,318 | $10,930,217 | 209,318 | $10,248,200 |
| 2024-07 | 0 | $0 | 2,269 | $77,200 | 0 | $0 |
| 2024-05 | 0 | $0 | 20,175 | $770,543 | 20,000 | $528,400 |
| 2024-04 | 0 | $0 | 5,981 | $151,222 | 0 | $0 |
| 2024-01 | 0 | $0 | 30,206 | $834,624 | 10,000 | $270,500 |
| 2023-12 | 7,700 | $198,737 | 0 | $0 | 0 | $0 |
| 2023-09 | 0 | $0 | 11,666 | $464,843 | 11,666 | $324,898 |
| 2023-06 | 0 | $0 | 1,000 | $44,860 | 0 | $0 |
| 2023-05 | 0 | $0 | 50,020 | $2,884,471 | 32,768 | $576,064 |
| 2023-04 | 0 | $0 | 84,315 | $4,367,292 | 78,044 | $2,271,708 |
| 2023-03 | 0 | $0 | 51,280 | $2,347,426 | 43,917 | $1,386,679 |
| 2023-01 | 0 | $0 | 15,894 | $690,740 | 0 | $0 |
| 2022-10 | 0 | $0 | 6,901 | $379,628 | 6,901 | $212,964 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2026-01-12 | Pauwels Eric (CHIEF BUSINESS OFFICER) | Sale | 1,024 | 78.70 | 80,588 |
| 2026-01-09 | Boulding Mark Elliott (EXEC. VP AND CLO) | Sale | 2,314 | 78.56 | 181,794 |
| 2026-01-09 | Pauwels Eric (CHIEF BUSINESS OFFICER) | Sale | 1,722 | 77.41 | 133,300 |
| 2026-01-08 | Klein Matthew B. (CHIEF EXECUTIVE OFFICER) | Sale | 2,514 | 76.45 | 192,195 |
| 2026-01-08 | Utter Christine Marie (SVP, CHIEF ACCOUNTING OFFICER) | Sale | 1,034 | 76.45 | 79,049 |
| 2026-01-08 | Golden Lee Scott (EVP & CHIEF MEDICAL OFFICER) | Sale | 866 | 76.45 | 66,205 |
| 2026-01-08 | Boulding Mark Elliott (EXEC. VP AND CLO) | Sale | 4,033 | 76.69 | 309,302 |
| 2026-01-08 | Almstead Neil Gregory (CHIEF TECHNICAL OPS OFFICER) | Sale | 940 | 76.45 | 71,863 |
| 2026-01-08 | Pauwels Eric (CHIEF BUSINESS OFFICER) | Sale | 4,602 | 76.62 | 352,591 |
| 2026-01-07 | Klein Matthew B. (CHIEF EXECUTIVE OFFICER) | Sale | 3,016 | 77.48 | 233,679 |
| 2026-01-07 | Utter Christine Marie (SVP, CHIEF ACCOUNTING OFFICER) | Sale | 1,235 | 77.45 | 95,650 |
| 2026-01-07 | Golden Lee Scott (EVP & CHIEF MEDICAL OFFICER) | Sale | 642 | 77.48 | 49,742 |
| 2026-01-07 | Boulding Mark Elliott (EXEC. VP AND CLO) | Sale | 4,879 | 77.87 | 379,932 |
| 2026-01-07 | Boulding Mark Elliott (EXEC. VP AND CLO) | Option Ex | 3,376 | 38.10 | 128,625 |
| 2026-01-07 | Almstead Neil Gregory (CHIEF TECHNICAL OPS OFFICER) | Sale | 1,078 | 77.48 | 83,523 |
| 2026-01-07 | Pauwels Eric (CHIEF BUSINESS OFFICER) | Sale | 1,352 | 77.48 | 104,752 |
| 2026-01-06 | Gravier Pierre (CHIEF FINANCIAL OFFICER) | Sale | 2,139 | 76.95 | 164,596 |
| 2026-01-06 | Klein Matthew B. (CHIEF EXECUTIVE OFFICER) | Sale | 5,149 | 76.95 | 396,215 |
| 2026-01-06 | Utter Christine Marie (SVP, CHIEF ACCOUNTING OFFICER) | Sale | 1,381 | 76.95 | 106,267 |
| 2026-01-06 | Golden Lee Scott (EVP & CHIEF MEDICAL OFFICER) | Sale | 1,340 | 76.95 | 103,113 |
| 2026-01-06 | Boulding Mark Elliott (EXEC. VP AND CLO) | Sale | 1,739 | 76.95 | 133,816 |
| 2026-01-06 | Almstead Neil Gregory (CHIEF TECHNICAL OPS OFFICER) | Sale | 1,333 | 76.95 | 102,574 |
| 2026-01-06 | Pauwels Eric (CHIEF BUSINESS OFFICER) | Sale | 1,789 | 76.95 | 137,663 |
| 2026-01-05 | Reeve Emma | Sale | 734 | 76.00 | 55,784 |
| 2026-01-05 | Reeve Emma | Option Ex | 734 | 46.54 | 34,160 |
| 2026-01-05 | Boulding Mark Elliott (EXEC. VP AND CLO) | Sale | 2,266 | 75.94 | 172,073 |
| 2026-01-05 | Boulding Mark Elliott (EXEC. VP AND CLO) | Option Ex | 2,266 | 39.42 | 89,325 |
| 2026-01-02 | Steele Glenn Jr Md Phd | Sale | 12,000 | 76.35 | 916,199 |
| 2026-01-02 | Steele Glenn Jr Md Phd | Option Ex | 12,000 | 30.86 | 370,320 |
| 2025-12-30 | Klein Matthew B. (CHIEF EXECUTIVE OFFICER) | Sale | 8,089 | 76.64 | 619,940 |
| 2025-12-19 | Pauwels Eric (CHIEF BUSINESS OFFICER) | Sale | 20,508 | 77.05 | 1,580,182 |
| 2025-12-19 | Pauwels Eric (CHIEF BUSINESS OFFICER) | Option Ex | 20,508 | 50.33 | 1,032,167 |
| 2025-12-18 | Pauwels Eric (CHIEF BUSINESS OFFICER) | Sale | 3,202 | 75.03 | 240,246 |
| 2025-12-18 | Pauwels Eric (CHIEF BUSINESS OFFICER) | Option Ex | 3,202 | 50.33 | 161,156 |
| 2025-12-17 | Pauwels Eric (CHIEF BUSINESS OFFICER) | Sale | 40,290 | 75.61 | 3,046,165 |
| 2025-12-17 | Pauwels Eric (CHIEF BUSINESS OFFICER) | Option Ex | 40,290 | 50.33 | 2,027,795 |
| 2025-12-16 | Schmertzler Michael | Option Ex | 24,000 | 30.86 | 740,640 |
| 2025-12-03 | Reeve Emma | Sale | 733 | 78.62 | 57,628 |
| 2025-12-03 | Reeve Emma | Option Ex | 733 | 46.54 | 34,113 |
| 2025-12-02 | Klein Matthew B. (CHIEF EXECUTIVE OFFICER) | Sale | 3,428 | 79.07 | 271,051 |
| 2025-11-25 | Jacobson Allan Steven | Sale | 14,199 | 84.00 | 1,192,716 |
| 2025-11-25 | Jacobson Allan Steven | Option Ex | 14,199 | 14.62 | 207,589 |
| 2025-11-25 | Almstead Neil Gregory (CHIEF TECHNICAL OPS OFFICER) | Sale | 71,928 | 83.89 | 6,034,327 |
| 2025-11-25 | Almstead Neil Gregory (CHIEF TECHNICAL OPS OFFICER) | Option Ex | 71,928 | 27.02 | 1,943,206 |
| 2025-11-24 | Jacobson Allan Steven | Sale | 11,801 | 80.14 | 945,732 |
| 2025-11-24 | Jacobson Allan Steven | Option Ex | 11,801 | 14.62 | 172,530 |
| 2025-11-24 | Almstead Neil Gregory (CHIEF TECHNICAL OPS OFFICER) | Sale | 35,572 | 80.16 | 2,851,380 |
| 2025-11-24 | Almstead Neil Gregory (CHIEF TECHNICAL OPS OFFICER) | Option Ex | 35,572 | 27.02 | 961,013 |
| 2025-11-21 | Reeve Emma | Sale | 10,000 | 79.50 | 795,000 |
| 2025-11-21 | Reeve Emma | Option Ex | 10,000 | 51.16 | 511,599 |
| 2025-11-17 | Boulding Mark Elliott (EXEC. VP AND CLO) | Sale | 2,812 | 76.45 | 214,977 |
| 2025-11-17 | Boulding Mark Elliott (EXEC. VP AND CLO) | Option Ex | 2,812 | 25.69 | 72,240 |
| 2025-11-12 | Reeve Emma | Sale | 7,333 | 74.50 | 546,308 |
| 2025-11-12 | Reeve Emma | Option Ex | 7,333 | 46.54 | 341,277 |
| 2025-10-30 | Reeve Emma | Sale | 15,666 | 69.50 | 1,088,787 |
| 2025-10-30 | Reeve Emma | Option Ex | 12,000 | 38.10 | 457,200 |
| 2025-10-07 | Boulding Mark Elliott (EXEC. VP AND CLO) | Sale | 3,375 | 63.89 | 215,618 |
| 2025-10-07 | Boulding Mark Elliott (EXEC. VP AND CLO) | Option Ex | 3,375 | 38.10 | 128,587 |
| 2025-10-06 | Boulding Mark Elliott (EXEC. VP AND CLO) | Sale | 2,266 | 65.07 | 147,448 |
| 2025-10-06 | Boulding Mark Elliott (EXEC. VP AND CLO) | Option Ex | 2,266 | 39.42 | 89,325 |
| 2025-10-03 | Reeve Emma | Sale | 25,562 | 66.02 | 1,687,526 |
| 2025-10-03 | Reeve Emma | Option Ex | 25,562 | 35.36 | 903,795 |
| 2025-10-03 | Jacobson Allan Steven | Sale | 12,000 | 65.00 | 780,000 |
| 2025-10-03 | Jacobson Allan Steven | Option Ex | 12,000 | 30.86 | 370,320 |
| 2025-10-03 | Boulding Mark Elliott (EXEC. VP AND CLO) | Sale | 22,655 | 65.71 | 1,488,682 |
| 2025-10-03 | Boulding Mark Elliott (EXEC. VP AND CLO) | Option Ex | 22,655 | 39.42 | 893,060 |
| 2025-10-03 | Almstead Neil Gregory (CHIEF TECHNICAL OPS OFFICER) | Sale | 55,000 | 66.37 | 3,650,460 |
| 2025-10-03 | Almstead Neil Gregory (CHIEF TECHNICAL OPS OFFICER) | Option Ex | 55,000 | 30.86 | 1,697,300 |
| 2025-09-12 | Boulding Mark Elliott (EXEC. VP AND CLO) | Sale | 24,585 | 61.48 | 1,511,608 |
| 2025-09-12 | Boulding Mark Elliott (EXEC. VP AND CLO) | Option Ex | 24,585 | 38.10 | 936,688 |
| 2025-09-11 | Reeve Emma | Sale | 15,705 | 59.50 | 934,447 |
| 2025-09-11 | Reeve Emma | Option Ex | 10,837 | 29.66 | 321,425 |
| 2025-09-11 | Boulding Mark Elliott (EXEC. VP AND CLO) | Sale | 22,664 | 61.00 | 1,382,504 |
| 2025-09-11 | Boulding Mark Elliott (EXEC. VP AND CLO) | Option Ex | 22,664 | 38.10 | 863,498 |
| 2025-09-09 | Southwell David P | Sale | 12,000 | 58.34 | 700,080 |
| 2025-09-09 | Southwell David P | Option Ex | 12,000 | 30.86 | 370,320 |
| 2025-09-08 | Pauwels Eric (CHIEF BUSINESS OFFICER) | Sale | 39,850 | 56.90 | 2,267,584 |
| 2025-09-08 | Pauwels Eric (CHIEF BUSINESS OFFICER) | Option Ex | 39,850 | 17.83 | 710,645 |
| 2025-08-28 | Jacobson Allan Steven | Sale | 1,667 | 50.15 | 83,600 |
| 2025-08-15 | Boulding Mark Elliott (EXEC. VP AND CLO) | Sale | 2,813 | 48.58 | 136,655 |
| 2025-08-15 | Boulding Mark Elliott (EXEC. VP AND CLO) | Option Ex | 2,813 | 25.69 | 72,265 |
| 2025-08-05 | Klein Matthew B. (CHIEF EXECUTIVE OFFICER) | Sale | 10,739 | 51.74 | 555,635 |
| 2025-07-15 | Gravier Pierre (CHIEF FINANCIAL OFFICER) | Sale | 7,548 | 49.46 | 373,323 |
| 2025-04-22 | Klein Matthew B. (CHIEF EXECUTIVE OFFICER) | Sale | 2,804 | 48.74 | 136,655 |
| 2025-04-02 | Golden Lee Scott (EVP & CHIEF MEDICAL OFFICER) | Sale | 897 | 46.95 | 42,114 |
| 2025-03-17 | Pauwels Eric (CHIEF BUSINESS OFFICER) | Sale | 6,762 | 56.96 | 385,163 |
| 2025-03-14 | Pauwels Eric (CHIEF BUSINESS OFFICER) | Sale | 4,458 | 55.19 | 246,037 |
| 2025-03-13 | Okey Stephanie | Sale | 5,000 | 54.00 | 270,000 |
| 2025-03-12 | Boulding Mark Elliott (EXEC. VP AND CLO) | Sale | 15,521 | 53.27 | 826,803 |
| 2025-03-12 | Boulding Mark Elliott (EXEC. VP AND CLO) | Option Ex | 15,521 | 33.02 | 512,503 |
| 2025-03-11 | Boulding Mark Elliott (EXEC. VP AND CLO) | Sale | 7,381 | 53.02 | 391,303 |
| 2025-03-11 | Boulding Mark Elliott (EXEC. VP AND CLO) | Option Ex | 7,381 | 33.02 | 243,720 |
| 2025-03-10 | Boulding Mark Elliott (EXEC. VP AND CLO) | Sale | 68,039 | 52.89 | 3,598,582 |
| 2025-03-10 | Boulding Mark Elliott (EXEC. VP AND CLO) | Option Ex | 68,039 | 30.58 | 2,080,428 |
| 2025-03-04 | Jacobson Allan Steven | Sale | 1,230 | 51.52 | 63,369 |
| 2025-02-20 | Gravier Pierre (CHIEF FINANCIAL OFFICER) | Sale | 1,167 | 50.12 | 58,494 |
| 2025-02-20 | Klein Matthew B. (CHIEF EXECUTIVE OFFICER) | Sale | 3,895 | 50.12 | 195,232 |
| 2025-02-20 | Utter Christine Marie (SVP, CHIEF ACCOUNTING OFFICER) | Sale | 878 | 50.12 | 44,008 |
| 2025-02-20 | Golden Lee Scott (EVP & CHIEF MEDICAL OFFICER) | Sale | 962 | 50.12 | 48,219 |
| 2025-02-20 | Boulding Mark Elliott (EXEC. VP AND CLO) | Sale | 1,614 | 50.12 | 80,900 |
| 2025-02-20 | Almstead Neil Gregory (CHIEF TECHNICAL OPS OFFICER) | Sale | 1,612 | 50.12 | 80,799 |
| 2025-02-20 | Pauwels Eric (CHIEF EXECUTIVE OFFICER) | Sale | 1,567 | 50.12 | 78,544 |
| 2025-02-19 | Gravier Pierre (CHIEF FINANCIAL OFFICER) | Sale | 1,168 | 50.10 | 58,512 |
| 2025-02-19 | Klein Matthew B. (CHIEF EXECUTIVE OFFICER) | Sale | 3,897 | 50.10 | 195,224 |
| 2025-02-19 | Utter Christine Marie (SVP, CHIEF ACCOUNTING OFFICER) | Sale | 879 | 50.10 | 44,034 |
| 2025-02-19 | Golden Lee Scott (EVP & CHIEF MEDICAL OFFICER) | Sale | 795 | 50.10 | 39,826 |
| 2025-02-19 | Boulding Mark Elliott (EXEC. VP AND CLO) | Sale | 1,333 | 50.10 | 66,777 |
| 2025-02-19 | Almstead Neil Gregory (CHIEF TECHNICAL OPS OFFICER) | Sale | 1,334 | 50.10 | 66,828 |
| 2025-02-19 | Pauwels Eric (CHIEF EXECUTIVE OFFICER) | Sale | 1,378 | 50.10 | 69,032 |
| 2025-01-08 | Klein Matthew B. (CHIEF EXECUTIVE OFFICER) | Sale | 2,402 | 44.50 | 106,889 |
| 2025-01-08 | Utter Christine Marie (SVP, CHIEF ACCOUNTING OFFICER) | Sale | 1,662 | 44.50 | 73,959 |
| 2025-01-08 | Golden Lee Scott (EVP & CHIEF MEDICAL OFFICER) | Sale | 1,198 | 44.50 | 53,311 |
| 2025-01-08 | Boulding Mark Elliott (EXEC. VP AND CLO) | Sale | 1,998 | 44.50 | 88,911 |
| 2025-01-08 | Almstead Neil Gregory (CHIEF TECHNICAL OPS OFFICER) | Sale | 1,659 | 44.50 | 73,825 |
| 2025-01-08 | Pauwels Eric (CHIEF EXECUTIVE OFFICER) | Sale | 2,136 | 44.50 | 95,052 |
| 2025-01-07 | Klein Matthew B. (CHIEF EXECUTIVE OFFICER) | Sale | 2,142 | 45.34 | 97,118 |
| 2025-01-07 | Utter Christine Marie (SVP, CHIEF ACCOUNTING OFFICER) | Sale | 1,291 | 45.34 | 58,533 |
| 2025-01-07 | Golden Lee Scott (EVP & CHIEF MEDICAL OFFICER) | Sale | 810 | 45.34 | 36,725 |
| 2025-01-07 | Boulding Mark Elliott (EXEC. VP AND CLO) | Sale | 1,543 | 45.34 | 69,959 |
| 2025-01-07 | Almstead Neil Gregory (CHIEF TECHNICAL OPS OFFICER) | Sale | 1,320 | 45.34 | 59,848 |
| 2025-01-07 | Pauwels Eric (CHIEF EXECUTIVE OFFICER) | Sale | 1,599 | 45.34 | 72,498 |
| 2024-12-03 | Boulding Mark Elliott (EXEC. VP AND CLO) | Sale | 10,308 | 53.50 | 551,478 |
| 2024-12-03 | Boulding Mark Elliott (EXEC. VP AND CLO) | Option Ex | 10,308 | 33.02 | 340,370 |
| 2024-12-02 | Utter Christine Marie (SVP, CHIEF ACCOUNTING OFFICER) | Sale | 17,800 | 51.89 | 923,642 |
| 2024-12-02 | Utter Christine Marie (SVP, CHIEF ACCOUNTING OFFICER) | Option Ex | 17,800 | 51.00 | 907,800 |
| 2024-12-02 | Boulding Mark Elliott (EXEC. VP AND CLO) | Sale | 85,600 | 52.22 | 4,469,604 |
| 2024-12-02 | Boulding Mark Elliott (EXEC. VP AND CLO) | Option Ex | 85,600 | 51.00 | 4,365,600 |
| 2024-12-02 | Almstead Neil Gregory (CHIEF TECHNICAL OPS OFFICER) | Sale | 71,610 | 52.31 | 3,746,133 |
| 2024-12-02 | Almstead Neil Gregory (CHIEF TECHNICAL OPS OFFICER) | Option Ex | 71,610 | 51.00 | 3,652,110 |
| 2024-12-02 | Zeldis Jerome B | Sale | 24,000 | 51.64 | 1,239,360 |
| 2024-12-02 | Zeldis Jerome B | Option Ex | 24,000 | 40.93 | 982,320 |
| 2024-07-16 | Gravier Pierre (CHIEF FINANCIAL OFFICER) | Sale | 2,269 | 34.02 | 77,200 |
| 2024-05-22 | Zeldis Jerome B | Sale | 20,000 | 38.24 | 764,800 |
| 2024-05-22 | Zeldis Jerome B | Option Ex | 20,000 | 26.42 | 528,400 |
| 2024-05-07 | Golden Lee Scott (EVP & CHIEF MEDICAL OFFICER) | Sale | 175 | 32.82 | 5,743 |
| 2024-04-19 | Klein Matthew B. (CHIEF EXECUTIVE OFFICER) | Sale | 3,361 | 24.89 | 83,668 |
| 2024-04-17 | Klein Matthew B. (CHIEF EXECUTIVE OFFICER) | Sale | 1,307 | 25.14 | 32,851 |
| 2024-04-17 | Pauwels Eric (CHIEF EXECUTIVE OFFICER) | Sale | 787 | 25.14 | 19,781 |
| 2024-04-02 | Golden Lee Scott (EVP & CHIEF MEDICAL OFFICER) | Sale | 526 | 28.37 | 14,922 |
| 2024-01-30 | Utter Christine Marie (SVP, CHIEF ACCOUNTING OFFICER) | Sale | 318 | 27.25 | 8,665 |
| 2024-01-30 | Boulding Mark Elliott (EXEC. VP AND CLO) | Sale | 794 | 27.25 | 21,637 |
| 2024-01-30 | Almstead Neil Gregory (CHIEF TECHNICAL OPS OFFICER) | Sale | 646 | 27.25 | 17,604 |
| 2024-01-30 | Pauwels Eric (CHIEF BUSINESS OFFICER) | Sale | 366 | 27.25 | 9,973 |
| 2024-01-22 | Jacobson Allan Steven | Sale | 10,000 | 27.38 | 273,800 |
| 2024-01-22 | Jacobson Allan Steven | Option Ex | 10,000 | 27.05 | 270,500 |
| 2024-01-09 | Utter Christine Marie (SVP, FINANCE & CAO) | Sale | 1,653 | 29.02 | 47,961 |
| 2024-01-09 | Pauwels Eric (CHIEF BUSINESS OFFICER) | Sale | 2,065 | 29.02 | 59,915 |
| 2024-01-08 | Utter Christine Marie (SVP, FINANCE & CAO) | Sale | 1,188 | 28.64 | 34,024 |
| 2024-01-08 | Pauwels Eric (CHIEF BUSINESS OFFICER) | Sale | 1,569 | 28.64 | 44,936 |
| 2024-01-08 | Schmertzler Michael | Sale | 1,500 | 27.81 | 41,715 |
Insider trading activities including stock purchases, stock sales, and option exercises of PTCT listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Ptc Therapeutics, Inc. (symbol PTCT, CIK number 1070081) see the Securities and Exchange Commission (SEC) website.